Under anesthesia, patients are often given muscle-relaxing neuromuscular blockers to make intubations easier and reduce the skeletal muscle tone during surgery. Using a drug to remove the blocking ...

Patients receiving neuromuscular blocking medications as part of their anesthetic regimen should be carefully monitored to ensure the best care and outcomes, according to recent—and independently ...

The US Food and Drug Administration (FDA) is notifying healthcare providers about the temporary absence of the words "paralyzing agent" on the vial caps of two neuromuscular blocking agents: ...

Paralytic drugs, or neuromuscular blocking agents (NMBAs), are powerful muscle relaxants used to prevent muscle movement during surgical procedures. They're also used during critical care, such as ...

The latest guidance in addressing proper monitoring and reversal of neuromuscular blockade drugs during general anesthesia—a major advance in patient safety and satisfaction—was published today in ...

Acute respiratory distress syndrome (ARDS) is characterised by rapid-onset respiratory failure, diffuse alveolar damage and profound hypoxaemia. Mechanical ventilation with a lung-protective ...

Researchers have found that the use of intermediate-acting neuromuscular blocking agents is linked with postoperative respiratory problems, according to a study reported in Anesthesiology News. The ...